Product Name |
Fingolimod phosphate D4 |
Alternate Names |
Fingolimod Stable Isotopes, Stable Isotopes of Fingolimod |
CAT No. |
CS-O-03010
|
CAS No. |
1794828-93-5 |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
391.48 g/mol |
Mol. For. |
C₁₉H₃₀D₄NO₅P
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Fingolimod |
Purity |
98.47 |
Therapeutic |
Immunosuppressants |
Smileys |
NC(C([2H])([2H])O[P](O)(O)=O)(C([2H])([2H])O)CCC1=CC=C(CCCCCCCC)C=C1 |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Fingolimod phosphate D4 is a deuterated version of Fingolimod, a medication used to treat multiple sclerosis (MS). It is a sphingosine-1-phosphate receptor modulator that works by reducing the number of immune cells in the blood that contribute to the inflammation that causes MS. Fingolimod phosphate D4 is chemically identical to Fingolimod but contains four deuterium atoms, making it useful for scientific research purposes.
The chemical formula for Fingolimod phosphate D4 is C19H33D4NO2P, and its molecular weight is 366.55 g/mol. It is administered orally as a capsule in doses of 0.5mg once daily. It is metabolized in the liver and excreted in the urine and feces. The half-life of Fingolimod phosphate D4 is approximately six days.
Fingolimod phosphate D4 is primarily used in scientific laboratories to conduct studies on the pharmacokinetics, pharmacodynamics, and metabolism of Fingolimod. It is also used to develop new analytical methods for detecting Fingolimod in biological samples. It is not approved for clinical use and should only be used under the supervision of a qualified researcher.
In conclusion, Fingolimod phosphate D4 is a deuterated version of a medication used to treat MS. It is primarily used in scientific research for studying the pharmacokinetics, pharmacodynamics, and metabolism of the medication. It is not approved for clinical use and should only be used under the supervision of a qualified researcher.